Work

20-Hydroxycholecalciferol and 20,23-dihydroxycholecalciferol, products of vitamin D3 hydroxylation by P450-scc, decrease NF kappa B activity by increasing I kappa B alpha levels in normal human- and HaCaT-keratinocytes